Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
As of close of business last night, Arvinas Inc’s stock clocked out at $7.79, down -2.01% from its previous closing price of $7.95. In other words, the price has decreased by -$2.01 from its previous closing price. On the day, 1.65 million shares were traded. ARVN stock price reached its highest trading level at $7.98 during the session, while it also had its lowest trading level at $7.68.
Ratios:
To gain a deeper understanding of ARVN’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.58 and its Current Ratio is at 4.58. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
On May 05, 2025, Truist Downgraded its rating to Hold which previously was Buy but kept the price unchanged to $11.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jun 24 ’25 when Saik Andrew sold 5,700 shares for $7.61 per share. The transaction valued at 43,377 led to the insider holds 164,401 shares of the business.
Andrew Saik bought 5,927 shares of ARVN for $43,593 on Jun 24 ’25. On Jun 17 ’25, another insider, Cacace Angela M, who serves as the Chief Scientific Officer of the company, sold 2,583 shares for $7.49 each. As a result, the insider received 19,347 and left with 154,248 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ARVN now has a Market Capitalization of 568603008 and an Enterprise Value of -406583360. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.53 while its Price-to-Book (P/B) ratio in mrq is 0.86. Its current Enterprise Value per Revenue stands at -0.952 whereas that against EBITDA is 4.448.
Stock Price History:
The Beta on a monthly basis for ARVN is 2.24, which has changed by -0.7082397 over the last 52 weeks, in comparison to a change of 0.11708844 over the same period for the S&P500. Over the past 52 weeks, ARVN has reached a high of $34.11, while it has fallen to a 52-week low of $5.90. The 50-Day Moving Average of the stock is 5.44%, while the 200-Day Moving Average is calculated to be -51.78%.
Shares Statistics:
It appears that ARVN traded 2.56M shares on average per day over the past three months and 1675600 shares per day over the past ten days. A total of 73.00M shares are outstanding, with a floating share count of 63.64M. Insiders hold about 12.81% of the company’s shares, while institutions hold 88.81% stake in the company. Shares short for ARVN as of 1749772800 were 8325671 with a Short Ratio of 3.26, compared to 1747267200 on 8231632. Therefore, it implies a Short% of Shares Outstanding of 8325671 and a Short% of Float of 11.59.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
Its stock is currently analyzed by 17.0 different market analysts. The consensus estimate for the next quarter is -$0.84, with high estimates of -$0.4 and low estimates of -$1.48.
Analysts are recommending an EPS of between $0.71 and -$4.22 for the fiscal current year, implying an average EPS of -$1.43. EPS for the following year is -$3.48, with 16.0 analysts recommending between -$1.84 and -$5.76.
Revenue Estimates
A total of 19 analysts have provided revenue estimates for ARVN’s current fiscal year. The highest revenue estimate was $439.8M, while the lowest revenue estimate was $131.7M, resulting in an average revenue estimate of $287.5M. In the same quarter a year ago, actual revenue was $263.4MBased on 19 analysts’ estimates, the company’s revenue will be $153.92M in the next fiscal year. The high estimate is $417.93M and the low estimate is $16.6M.
